PET detection of epidermal growth factor receptor in colorectal cancer: a real predictor of response to cetuximab treatment?
β Scribed by M. A. Pantaleo; S. Fanti; P. L. Lollini; S. Boschi; G. Biasco
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 53 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Our purpose was to determine the clinical relevance of the detection of circulating tumor cells (CTCs) expressing urothelial and epithelial markers in bladder cancer patients. Sixtyβtwo patients who presented to Memorial SloanβKettering Cancer Center between July 2000 and September 2001
## Abstract Growth factor receptors of the tyrosine kinase family regulate proliferation of a variety of cell types. In some human cancers, the epidermal growth factor receptor (EGFR) and its ligands often are overexpressed, leading to both constitutive and autocrine activation. Intracellular signa
## Abstract The high frequency of epidermal growth factor receptor (__EGFR__) mutations in tyrosine kinase inhibitorβresponsive nonβsmallβcell lung cancer (NSCLC) cases is now well established, highlighting the predictive value of activating __EGFR__ mutations in guiding the clinical use of __EGFR_